These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 16275545)

  • 1. The dependence of serum interleukin-6 level on PPAR-alpha polymorphism in men with coronary atherosclerosis.
    Skoczynska A; Dobosz T; Poreba R; Turczyn B; Derkacz A; Zoledziewska M; Jonkisz A; Lebioda A
    Eur J Intern Med; 2005 Nov; 16(7):501-6. PubMed ID: 16275545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the PPARalpha L162V polymorphism, plasma lipoprotein levels, and atherosclerotic disease in patients with diabetes mellitus type 2 and in nondiabetic controls.
    Gouni-Berthold I; Giannakidou E; Müller-Wieland D; Faust M; Kotzka J; Berthold HK; Krone W
    Am Heart J; 2004 Jun; 147(6):1117-24. PubMed ID: 15199365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Val227Ala substitution in the peroxisome proliferator activated receptor alpha (PPAR alpha) gene associated with non-alcoholic fatty liver disease and decreased waist circumference and waist-to-hip ratio.
    Chen S; Li Y; Li S; Yu C
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1415-8. PubMed ID: 18853997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome.
    Rhee EJ; Oh KW; Lee WY; Kim SY; Oh ES; Baek KH; Kang MI; Kim SW
    Arch Med Res; 2006 Jan; 37(1):86-94. PubMed ID: 16314192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
    Paik JK; Kim OY; Koh SJ; Jang Y; Chae JS; Kim JY; Kim HJ; Hyun YJ; Cho JR; Lee JH
    Clin Chim Acta; 2007 May; 380(1-2):68-74. PubMed ID: 17335789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the PPAR-Alpha L162V polymorphism on the cardiovascular disease risk factor in response to n-3 polyunsaturated fatty acids.
    Caron-Dorval D; Paquet P; Paradis AM; Rudkowska I; Lemieux S; Couture P; Vohl MC
    J Nutrigenet Nutrigenomics; 2008; 1(4):205-12. PubMed ID: 19776627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of methylenetetrahydrofolate reductase C677T polymorphism with markers of subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study.
    Collings A; Raitakari OT; Juonala M; Rontu R; Kähönen M; Hutri-Kähönen N; Rönnemaa T; Marniemi J; Viikari JS; Lehtimäki T
    Scand J Clin Lab Invest; 2008; 68(1):22-30. PubMed ID: 17934972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor (PPAR) delta genetic polymorphism and its association with insulin resistance index and fasting plasma glucose concentrations in Chinese subjects.
    Hu C; Jia W; Fang Q; Zhang R; Wang C; Lu J; Xiang K
    Diabet Med; 2006 Dec; 23(12):1307-12. PubMed ID: 17116180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The L162V polymorphism of the peroxisome proliferator activated receptor alpha gene (PPARA) is not associated with type 2 diabetes, BMI or body fat composition.
    Silbernagel G; Stefan N; Hoffmann MM; Machicao-Arano F; Machann J; Schick F; Winkelmann BR; Boehm BO; Häring HU; Fritsche A; März W
    Exp Clin Endocrinol Diabetes; 2009 Mar; 117(3):113-8. PubMed ID: 18726867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the Pro12Ala variant of the peroxisome proliferator-activated receptor-gamma2 gene and increased 24-h diastolic blood pressure in obese patients with type II diabetes.
    Stefański A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Moleda P; Pilarska K
    J Hum Hypertens; 2006 Sep; 20(9):684-92. PubMed ID: 16625233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
    Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
    Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence.
    Zambon A; Gervois P; Pauletto P; Fruchart JC; Staels B
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):977-86. PubMed ID: 16424352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of distribution of leptin receptor gene polymorphism in obstructive sleep apnea patients.
    Popko K; Gorska E; Wasik M; Stoklosa A; Pływaczewski R; Winiarska M; Gorecka D; Sliwinski P; Demkow U
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):551-61. PubMed ID: 18204169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD14 C (-260)T polymorphism, atherosclerosis, elderly: role of cytokines and metallothioneins.
    Giacconi R; Caruso C; Lio D; Muti E; Cipriano C; Costarelli L; Saba V; Gasparini N; Malavolta M; Mocchegiani E
    Int J Cardiol; 2007 Aug; 120(1):45-51. PubMed ID: 17098305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma2 gene with small dense low-density lipoprotein in the general population.
    Hamada T; Kotani K; Tsuzaki K; Sano Y; Murata T; Tabata M; Sato S; Sakane N
    Metabolism; 2007 Oct; 56(10):1345-9. PubMed ID: 17884443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism is associated with reduced risk for ischemic stroke with type 2 diabetes.
    Lee BC; Lee HJ; Chung JH
    Neurosci Lett; 2006 Dec; 410(2):141-5. PubMed ID: 17084528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.
    Peng Y; Liu H; Liu F; Ouyang L; Cheng M; Gao L; Pan F; Liu Y; Chen X; Li J
    Nephrology (Carlton); 2008 Oct; 13(7):579-86. PubMed ID: 19161364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender-specific effect of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma-2 gene on obesity risk and leptin levels in a Tunisian population.
    Ben Ali S; Ben Yahia F; Sediri Y; Kallel A; Ftouhi B; Feki M; Elasmi M; Haj-Taieb S; Souheil O; Sanhagi H; Slimane H; Jemaa R; Kaabachi N
    Clin Biochem; 2009 Nov; 42(16-17):1642-7. PubMed ID: 19733160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of serum levels of inflammatory markers and allelic variant of interleukin-6 in patients with acute coronary syndrome and stable angina pectoris.
    Ozdemir O; Gundogdu F; Karakelleoglu S; Sevimli S; Pirim I; Acikel M; Arslan S; Serdar S
    Coron Artery Dis; 2008 Feb; 19(1):15-9. PubMed ID: 18281810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of inflammation and atherosclerosis in Egyptian patients with systemic lupus erythematosus.
    Sabry AA; Elbasyouni SR; Kalil AM; Abdel-Rahim M; Mohsen T; Sleem A
    Nephrology (Carlton); 2006 Aug; 11(4):329-35. PubMed ID: 16889573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.